Valuation: Haleon plc

Market Cap 31.51B 42.37B 36.79B 34.3B 59.59B 4,030B 60.25B 404B 158B 2,015B 159B 156B 6,675B P/E 2026 *
18.6x
P/E 2027 * 16.4x
Enterprise Value 38.4B 51.63B 44.83B 41.8B 72.62B 4,911B 73.41B 493B 193B 2,455B 194B 190B 8,134B EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.19x
Free-Float
97.15%
Yield 2026 *
2.25%
Yield 2027 * 2.5%
1 day-1.27%
1 week-6.09%
Current month-1.54%
1 month-1.81%
3 months+3.95%
6 months-9.44%
Current year-4.56%
1 week 355.72
Extreme 355.7238
379.6
1 month 354.1
Extreme 354.1
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.27%-6.09%+0.53%+11.17% 42.85B
-0.51%-8.60%+45.08%+148.21% 1T
+0.20%-4.42%+49.05%+50.81% 613B
-0.53%-7.37%+23.64%+65.03% 433B
+0.48%-2.77%+40.27%+34.96% 350B
+0.08%-4.45%+31.74%+39.89% 292B
+2.09%-9.27%+5.42%+7.61% 239B
+1.75%-8.29%-1.73%-42.05% 206B
+2.94%-0.78%+29.17%+60.32% 204B
+3.13%+0.69%+18.11%+71.90% 163B
Average +0.93%-4.74%+24.13%+44.78% 354.33B
Weighted average by Cap. +0.70%-5.59%+33.48%+70.30%

Financials

2026 *2027 *
Net sales 11.4B 15.33B 13.31B 12.41B 21.56B 1,458B 21.8B 146B 57.19B 729B 57.56B 56.3B 2,415B 11.89B 15.99B 13.88B 12.94B 22.48B 1,521B 22.73B 153B 59.64B 760B 60.03B 58.71B 2,519B
Net income 1.7B 2.28B 1.98B 1.85B 3.21B 217B 3.24B 21.76B 8.5B 108B 8.56B 8.37B 359B 1.93B 2.59B 2.25B 2.1B 3.64B 246B 3.68B 24.71B 9.66B 123B 9.72B 9.51B 408B
Net Debt 6.89B 9.26B 8.04B 7.5B 13.02B 881B 13.17B 88.38B 34.55B 440B 34.77B 34.01B 1,459B 6.4B 8.6B 7.47B 6.96B 12.1B 818B 12.23B 82.07B 32.08B 409B 32.29B 31.58B 1,355B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-08-04 GBX 357.70 -1.27% 15,092,763
26-08-03 GBX 362.30 -0.28% 18,642,450
26-07-31 GBX 363.30 -1.44% 25,724,593
26-07-30 GBX 368.60 -2.92% 27,282,182
26-07-29 GBX 379.70 -0.32% 36,335,259
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.577GBP
Average target price
4.178GBP
Spread / Average Target
+16.79%

Quarterly revenue - Rate of surprise